REGENXBIO Inc.

RGNXNASDAQ • USD
7.65 USD
↗ 0.00 (0.07%)🟢PRE MARKET (AS OF 03:59 AM EST)
🟢Market: OPEN

RGNX is currently priced at $7.65. The technical outlook is "Neutral" and the fundamental picture shows "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, RGNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$7.65
High?$7.65
Low?$7.65
Prev. Close?$7.64
Volume?0
Avg. Volume?1.4M
Bid / Ask
Bid?$6.22 × 100
Ask?$9.07 × 100
Spread?$2.85
Midpoint?$7.65
Valuation & Ratios
Market Cap?505.2M
Shares Out?66.1M
Float?51.7M
Float %?78.4%
P/E Ratio?N/A
P/B Ratio?3.41
EPS?-$2.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Employees
371
Market Cap
505.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2015-09-17
Address
9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Phone: 240-552-8181
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
5
Short Sent.?
45
Piotroski F-Score?3/9Weak
Altman Z-Score?-2.81Distress
Confidence?64%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.68%High
Short Interest?10.2M
Days to Cover?8.3
Free Float51.7M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.74Strong
Quick Ratio?4.74Strong
Cash Ratio?1.42Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
50
3.41FAIR▾
P/S?
Peers
100
S&P
47
3.28FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.4CHEAP▾
EV/Sales?
Peers
100
S&P
65
2.66CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-118.4%WEAK▾
ROA?
S&P
3
-37.6%WEAK▾
Cash Flow & Enterprise
FCF?$-154802000
Enterprise Value?$409.4M
Fundamentals ratios updated end of day